Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_assertion type Assertion NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_head.
- NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_assertion description "[The EGR1 transactivator is overexpressed in prostate cancer, and its expression pattern suggests that EGR1 could potentially regulate a number of steps involved in initiation and progression of prostate cancer, such as mitogenesis, invasiveness, angiogenesis, and metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance.
- NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_assertion evidence source_evidence_literature NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance.
- NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_assertion SIO_000772 10984481 NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance.
- NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_assertion wasDerivedFrom befree-20140225 NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance.
- NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_assertion wasGeneratedBy ECO_0000203 NP623379.RA_XYF4l2N5S2zzwfUsXXR7oNNTp_gudZL8r0rmfVvUuw130_provenance.